Pappas Capital — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Aktis Oncologyaktisoncology.com inNASDAQ: AKTSSep 2024

Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors.

BiotechHealthtechMedical DevicesBoston, US

Todd Foley(Co-founder and Chairman)in Patrick Baeuerle(Co-founder & Advisor)inShulamit Ron-Bigger(Executive Officer)inKyle D. Kuvalanka(Chief Financial Officer)inAkos Czibere(Chief Medical Officer)in Paul L. Feldman(Chief Scientific Officer)in

Co-investorsAndreessen Horowitz EcoR1 Capital MPM BioImpact MRL Ventures Fund RA Capital TCG Crossover +5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.